Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs.
Faucher C, Le Corroller Soriano AG, Esterni B, Vey N, Stoppa AM, Chabannon C, Mohty M, Michallet M, Bay JO, Genre D, Maraninchi D, Viens P, Moatti JP, Blaise D. Faucher C, et al. Among authors: genre d. Bone Marrow Transplant. 2012 Apr;47(4):549-55. doi: 10.1038/bmt.2011.126. Epub 2011 Jul 4. Bone Marrow Transplant. 2012. PMID: 21725375 Clinical Trial.
Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy.
Viret F, Chabannon C, Sainty D, Genre D, Gonçalves A, Arnoulet C, Gravis G, Bertucci F, Houvenaeghel G, Jacquemier J, Bardou VJ, Ladaique P, Braud AC, Maraninchi D, Viens P. Viret F, et al. Among authors: genre d. Bone Marrow Transplant. 2003 Dec;32(11):1059-64. doi: 10.1038/sj.bmt.1704283. Bone Marrow Transplant. 2003. PMID: 14625576 Clinical Trial.
Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens.
Genre D, Viens P, Bertucci F, Chabannon C, Gravis G, Braud AC, Camerlo J, Houvenaeghel G, Moutardier V, Goncalvez A, Protière C, Bardou VJ, Maraninchi D. Genre D, et al. Bone Marrow Transplant. 2002 Jun;29(11):881-6. doi: 10.1038/sj.bmt.1703556. Bone Marrow Transplant. 2002. PMID: 12080351 Clinical Trial.
Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapy.
Bagnis C, Chabannon C, Gravis G, Imbert AM, Maroc C, Bardin F, Ladaique P, Viret F, Genre D, Faucher C, Stoppa AM, Vey N, Blaise D, Maraninchi D, Viens P, Mannoni P. Bagnis C, et al. Among authors: genre d. Exp Hematol. 2002 Feb;30(2):108-15. doi: 10.1016/s0301-472x(01)00773-1. Exp Hematol. 2002. PMID: 11823045 Free article.
The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell technology.
Chabannon C, Novakovitch G, Blache JL, Olivero S, Camerlo J, Genre D, Maraninchi D, Viens P. Chabannon C, et al. Among authors: genre d. Hematol Cell Ther. 1999 Apr;41(2):78-81. doi: 10.1007/s00282-999-0078-7. Hematol Cell Ther. 1999. PMID: 10344557
Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamide.
Chabannon C, Blache JL, Sielleur I, Douville J, Faucher C, Gravis G, Arnoulet C, Oziel-Taieb S, Blaise D, Novakovitch G, Camerlo J, Chabbert I, Genre D, Appel M, Armstrong D, Maraninchi D, Viens P. Chabannon C, et al. Among authors: genre d. Int J Oncol. 1999 Sep;15(3):511-8. doi: 10.3892/ijo.15.3.511. Int J Oncol. 1999. PMID: 10427133 Clinical Trial.
39 results